Websites Hosted in dnadns2e.gene.com Nameserver
The Nameserver dnadns2e.gene.com have a IP Address of 72.34.128.76 which is hosted on United States.
Lucentis® (ranibizumab injection) for Wet AMD, DME & RVO
Discover Lucentis® (ranibizumab injection), a prescription medicine for the treatment of patients with wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription...
Avastin® (bevacizumab) | Official Healthcare Professional (HCP) Website
For US HCPs: Access resources for Avastin (bevacizumab) solution for IV infusion, including efficacy data, safety profiles, and information on dosing and usage. Avastin is indicated for the treatment of metastatic renal cell carcinoma in combination with interferon alfa. Avastin is indicated for the treatment of...
Avastin® (bevacizumab) | Official Patient & Caregiver Website
Learn about Avastin (bevacizumab) solution for IV infusion, including benefits & risks, possible side effects, patient support, and options for financial help. Glioblastoma (GBM) Avastin is approved to treat glioblastoma (GBM) when taken alone in adult patients whose cancer has progressed after prior treatment...
Retina Eye Exam for Preventing Vision Loss from Diabetes | Diabetes Eye Check
Learn how diabetes can lead to vision loss and what yearly retina eye exams can do to help.
Get Involved in the Hemophilia Community | Genentech in Hemophilia
Connect with a Hemophilia Community Clinical Education Manager (CEM) to get your questions on hemophilia and Genentech products answered. Find opportunities to get involved in hemophilia events and workshops.
Roche - Doing now what patients need next
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Advanced Lung Cancer Immunotherapy Treatment | TECENTRIQ® (atezolizumab)
Find information about TECENTRIQ® (atezolizumab), which is now approved for a type of metastatic non-small cell lung cancer (NSCLC). See full safety for more information.
CHALLENGE ACCEPTED: Hemophilia Web Series | Genentech in Hemophilia
Watch the CHALLENGE ACCEPTED web series, hosted by Justin Wilman, where people with hemophilia challenge what it means to live with a bleeding disorder.
HEMLIBRA® (emicizumab-kxwh) Resources for Download
Find helpful tools and downloadable resources and content for HEMLIBRA® (emicizumab-kxwh) patients and caregivers. See full safety and BOXED WARNING.